BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/03/2022

FDA Revokes Authorization for Abbott COVID-19 Test

The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for Abbott Diagnostics Scarborough, Inc.'s BinaxNOW COVID-19 Ag Card 2 Home Test, citing reasons for the revocation as outlined in the document.

Source: Federal Register — Food and Drug AdministrationOpen original release →